Public Private Partnerships: A working model for open innovation in Drug Discovery
Add bookmark
Public Private Partnerships: A working model for open innovation in Drug Discovery
Add bookmarkLooking to comprehensive strategies for structuring and funding innovation driven in non-clinical co-operations through the experiences of the Structural Genomics Consortium (SGC) at University of Oxford. Dr Wen Hwa Lee, the Strategic Alliances Manager talks to Pharma IQ on benefitting from pre-competitive research and shares insight in a compound discovery case study and the journey involved to bring this into the public domain.
[inlinead]
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Tags:
discovery partnerships
Compound Discovery
Public Private Partnerships
Innovation in Drug Discovery
